| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 1.418 | 731 | 595 | 583 | 563 | 546 | 534 | 0 | 0 | - |
| Gross Profit/Loss - EUR | -1.418 | -731 | -595 | -583 | -563 | -546 | -534 | 0 | 0 | - |
| Net Profit/Loss - EUR | -1.418 | -731 | -595 | -583 | -563 | -546 | -534 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - United Systems Company For Medicines, Medical And
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 710 | 506 | 371 | 641 | 157 | 154 | 26 | 26 | 26 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Cash | 710 | 506 | 371 | 641 | 157 | 154 | 26 | 26 | 26 | - |
| Shareholders Funds | -1.193 | -1.912 | -2.475 | -3.013 | -3.518 | -3.997 | -4.442 | -4.456 | -4.442 | - |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | - |
| Debts | 1.948 | 2.418 | 2.846 | 3.653 | 3.675 | 4.151 | 4.468 | 4.481 | 4.468 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2660 - 2660" | |||||||||
| CAEN Financial Year |
2660
|
|||||||||
Comments - United Systems Company For Medicines, Medical And Laboratory Equipment Trading Srl